-+ 0.00%
-+ 0.00%
-+ 0.00%

Can Arteris (AIP) Justify Its Valuation As Its IC Link Collaboration Draws Attention?

Simply Wall St·07/11/2026 17:26:07
Listen to the news

Arteris (AIP) has drawn fresh attention after announcing a collaboration with IC-Link by imec to deploy its network-on-chip IP in reference designs for next-generation AI and high-performance computing chiplets and ASICs.

See our latest analysis for Arteris.

The new collaboration headlines come after a sharp run in Arteris, with the latest share price at $34.77 and a 90 day share price return of 79.78%, alongside a 1 year total shareholder return of 282.51%. This signals strong but volatile momentum.

If this AI infrastructure story has your attention, it can be useful to see what else is moving in the space via the 52 AI infrastructure stocks

After Arteris surged toward analysts’ price target, the stock now trades at only a small discount to the consensus. Is that move already baking in the upside, or does fair value still sit meaningfully higher within the current estimate range?

Most Popular Narrative: 7.9% Undervalued

With Arteris last closing at $34.77 against a narrative fair value of $37.75, the current setup reflects optimism that still sits below that reference point.

The ongoing industry transition to chiplet-based and heterogeneous integration architectures is expanding Arteris' addressable market, with chiplet-related design starts expected to rise from 5% to 30% in coming years; this structural trend supports both higher sales volume and increased average selling prices, benefiting future top-line revenue.

Read the complete narrative.

Want to see what kind of revenue trajectory and margin shift this narrative leans on, and how those assumptions feed into that higher fair value.

Result: Fair Value of $37.75 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, investors in Arteris also need to weigh the ongoing net losses and customer concentration, since setbacks on either front could quickly challenge this view of the shares as undervalued.

Find out about the key risks to this Arteris narrative.

Another View on Arteris Valuation

The earlier narrative framed Arteris as about 7.9% undervalued relative to a $37.75 fair value, but the current pricing on sales tells a tougher story. The stock trades on a P/S ratio of 20.9x, compared with 3.5x for the US Software industry and 4.3x for peers, while the fair ratio sits at 7.5x. That gap suggests the market is already paying a rich premium, so the question is whether you think Arteris can grow into that multiple before sentiment cools.

See what the numbers say about this price — find out in our valuation breakdown.

NasdaqGM:AIP P/S Ratio as at Jul 2026
NasdaqGM:AIP P/S Ratio as at Jul 2026

Next Steps

If the mixed signals around Arteris have you torn, take a closer look at the underlying data now and shape your own stance with the 1 key reward and 3 important warning signs.

Looking for more investment ideas beyond Arteris?

If Arteris has sharpened your focus, do not stop here. Simply Wall Street’s stock screener can quickly surface other opportunities that fit your approach and risk tolerance.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.